Potential new treatment for diabetes and fatty liver disease
A study, published in theBritish Journal of Pharmacology, indicates a new molecule, which promotes the production of the FGF21 hormone, has anti-diabetic and anti-obesogenic effects that may be useful in developing treatments for non-alcoholic fatty liver disease and diabetes.Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Alcoholism | Diabetes | Drugs & Pharmacology | Endocrinology | Fatty Liver Disease (FLD) | Hormones | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Science | Study | Urology & Nephrology